Leaflet NESYRGY 5mg / 10mg film-coated tablets


Indicated for: hypertension

Substance: nebivolol + amlodipine (beta blocker + calcium channel blocker)

ATC: C07FB12 (Cardiovascular system | Beta blocking agents, other combinations | Beta blocking agents and calcium channel blockers)

The combination of nebivolol and amlodipine is used for the treatment of hypertension in adult patients. Nebivolol is a beta-blocker that reduces heart rate and dilates blood vessels, while amlodipine is a calcium channel blocker that relaxes blood vessels.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor blood pressure.

Patients should be aware of potential side effects, such as dizziness, headaches, or peripheral edema. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, headaches, and peripheral edema. In rare cases, severe reactions such as bradycardia or heart failure may occur. Patients should be informed of these risks before use.

General data about NESYRGY 5mg / 10mg

  • Substance: nebivolol + amlodipine
  • Date of last drug list: 01-03-2025
  • Commercial code: W70915001
  • Concentration: 5mg / 10mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 7
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: SANECA PHARMACEUTICALS, A.S. - SLOVACIA
  • Holder: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. - LUXEMBURG
  • Number: 15817/2025/01
  • Shelf life: 2 years

Concentrations available for nebivolol + amlodipine

  • 5mg/10mg
  • 5mg/5mg